BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11115556)

  • 21. Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation.
    Sadato D; Ono T; Gotoh-Saito S; Kajiwara N; Nomura N; Ukaji M; Yang L; Sakimura K; Tajima Y; Oboki K; Shibasaki F
    FEBS Open Bio; 2018 Aug; 8(8):1188-1201. PubMed ID: 30087825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
    Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
    Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic mutations that contribute to breast cancer.
    Callahan R
    Biochem Soc Symp; 1998; 63():211-21. PubMed ID: 9513725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of truncated Int6/eIF3e in mammary alveolar epithelium leads to persistent hyperplasia and tumorigenesis.
    Mack DL; Boulanger CA; Callahan R; Smith GH
    Breast Cancer Res; 2007; 9(4):R42. PubMed ID: 17626637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
    Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
    Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts.
    Sarkar NH; Haga S; Lehner AF; Zhao W; Imai S; Moriwaki K
    Virology; 1994 Aug; 203(1):52-62. PubMed ID: 8030284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Int6 expression can predict survival in early-stage non-small cell lung cancer patients.
    Buttitta F; Martella C; Barassi F; Felicioni L; Salvatore S; Rosini S; D'Antuono T; Chella A; Mucilli F; Sacco R; Mezzetti A; Cuccurullo F; Callahan R; Marchetti A
    Clin Cancer Res; 2005 May; 11(9):3198-204. PubMed ID: 15867213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The function and clinical significance of eIF3 in cancer.
    Yin Y; Long J; Sun Y; Li H; Jiang E; Zeng C; Zhu W
    Gene; 2018 Oct; 673():130-133. PubMed ID: 29908282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers.
    Contegiacomo A; Pizzi C; De Marchis L; Alimandi M; Delrio P; Di Palma E; Petrella G; Ottini L; French D; Frati L
    Int J Cancer; 1995 Mar; 61(1):1-6. PubMed ID: 7705920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants.
    Ornitz DM; Cardiff RD; Kuo A; Leder P
    J Natl Cancer Inst; 1992 Jun; 84(11):887-92. PubMed ID: 1317463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.
    Brugger W; Triller N; Blasinska-Morawiec M; Curescu S; Sakalauskas R; Manikhas GM; Mazieres J; Whittom R; Ward C; Mayne K; Trunzer K; Cappuzzo F
    J Clin Oncol; 2011 Nov; 29(31):4113-20. PubMed ID: 21969500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of amplified int-2/FGF-3 gene in primary breast carcinomas using differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK; Nair S
    Int J Mol Med; 2001 Aug; 8(2):193-8. PubMed ID: 11445874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
    Lawson JS; Tran DD; Ford C; Rawlinson WD
    Breast Cancer Res Treat; 2004 Sep; 87(1):13-7. PubMed ID: 15377846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
    Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
    Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.